Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Electrophorus electricus | Acetylcholinesterase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | Acetylcholinesterase | 633 aa | 597 aa | 25.1 % |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | Acetylcholinesterase | 633 aa | 622 aa | 24.9 % |
Brugia malayi | Carboxylesterase family protein | Acetylcholinesterase | 633 aa | 620 aa | 28.4 % |
Echinococcus granulosus | BC026374 protein S09 family | Acetylcholinesterase | 633 aa | 690 aa | 31.7 % |
Drosophila melanogaster | CG10175 gene product from transcript CG10175-RE | Acetylcholinesterase | 633 aa | 549 aa | 30.4 % |
Loa Loa (eye worm) | hypothetical protein | Acetylcholinesterase | 633 aa | 576 aa | 23.4 % |
Echinococcus multilocularis | neuroligin | Acetylcholinesterase | 633 aa | 507 aa | 23.9 % |
Onchocerca volvulus | Molybdopterin synthase catalytic subunit homolog | Acetylcholinesterase | 633 aa | 576 aa | 28.8 % |
Echinococcus multilocularis | BC026374 protein (S09 family) | Acetylcholinesterase | 633 aa | 690 aa | 32.3 % |
Onchocerca volvulus | Acetylcholinesterase | 633 aa | 648 aa | 25.3 % | |
Brugia malayi | Carboxylesterase family protein | Acetylcholinesterase | 633 aa | 517 aa | 25.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0239 | 1 | 1 |
Echinococcus granulosus | roundabout 2 | 0.0109 | 0.3275 | 1 |
Echinococcus granulosus | carboxylesterase 5A | 0.0082 | 0.1842 | 0.3158 |
Brugia malayi | Carboxylesterase family protein | 0.0082 | 0.1842 | 0.075 |
Schistosoma mansoni | nephrin | 0.0087 | 0.21 | 0.892 |
Echinococcus granulosus | twitchin | 0.0087 | 0.21 | 0.4393 |
Echinococcus multilocularis | acetylcholinesterase | 0.0082 | 0.1842 | 0.3158 |
Echinococcus granulosus | acetylcholinesterase | 0.0082 | 0.1842 | 0.3158 |
Loa Loa (eye worm) | carboxylesterase | 0.0082 | 0.1842 | 0.075 |
Loa Loa (eye worm) | hypothetical protein | 0.0092 | 0.2355 | 0.1331 |
Echinococcus multilocularis | roundabout 2 | 0.0109 | 0.3275 | 1 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0092 | 0.2355 | 0.5607 |
Schistosoma mansoni | vesicular amine transporter | 0.0069 | 0.1181 | 0.5013 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.1842 | 0.075 |
Onchocerca volvulus | Tyrosine kinase homolog | 0.0164 | 0.6144 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0109 | 0.3275 | 0.2375 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0082 | 0.1842 | 0.075 |
Schistosoma mansoni | defective proboscis extension response (dpr)-related | 0.0069 | 0.1181 | 0.5013 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.1842 | 0.075 |
Echinococcus multilocularis | acetylcholinesterase | 0.0082 | 0.1842 | 0.3158 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0082 | 0.1842 | 0.3158 |
Schistosoma mansoni | Neurotrimin precursor (hNT) | 0.0069 | 0.1181 | 0.5013 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0082 | 0.1842 | 0.7821 |
Brugia malayi | Carboxylesterase family protein | 0.0082 | 0.1842 | 0.075 |
Echinococcus granulosus | neuroglian | 0.0087 | 0.21 | 0.4393 |
Echinococcus granulosus | acetylcholinesterase | 0.0082 | 0.1842 | 0.3158 |
Echinococcus multilocularis | neuroglian | 0.0087 | 0.21 | 0.4393 |
Loa Loa (eye worm) | hypothetical protein | 0.0109 | 0.3275 | 0.2375 |
Schistosoma mansoni | cell adhesion molecule | 0.0092 | 0.2355 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 18.11 umol/L | Inhibition of electric eel AChE after 30 mins by Ellman's method | ChEMBL. | 23434223 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.